Monitor for any reverse stock split announcement or other compliance plan before the April 12, 2027 deadline. If the stock fails to trade above $1.00 for 10 consecutive business days before that date, delisting risk escalates, likely pressuring the stock further.
Price Chart
Executive Summary
Cyngn Inc. received a Nasdaq deficiency notice on October 14, 2026, because its common stock closing bid price remained below $1.00 for 30 consecutive business days, violating the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company has 180 calendar days, until April 12, 2027, to regain compliance, and may be eligible for an additional 180-day period if it meets other initial listing standards and intends to cure via a reverse stock split. Failure to regain compliance could result in delisting, which would severely reduce institutional ownership and liquidity.
Key Facts
- Nasdaq notified Cyngn on October 14, 2026, that its common stock bid price was below $1.00 for 30 consecutive business days.
- The company has 180 calendar days, until April 12, 2027, to regain compliance with the minimum $1.00 bid price requirement.
- If compliance is not achieved by April 12, 2027, Cyngn may qualify for an additional 180-day period if it meets other Nasdaq initial listing standards and provides notice of intent to cure, potentially via a reverse stock split.
- If the company cannot cure the deficiency or is ineligible for additional time, Nasdaq will notify Cyngn that its securities will be subject to delisting, with a right to appeal to a Nasdaq Hearings Panel.
- There is no assurance that Cyngn will regain compliance or maintain compliance with any other Nasdaq continued listing requirement.
Financial Impact
Delisting risk for a micro-cap company trading below $1.00; no specific financial figures provided in the filing.
Risk Factors
- Failure to regain compliance by April 12, 2027, could lead to Nasdaq delisting.
- Even if eligible for a second 180-day compliance period, the company may not be able to cure the deficiency.
- A reverse stock split, if attempted, may not sustain the bid price above $1.00 and could further dilute or negatively impact the stock.
- Delisting would severely reduce liquidity and institutional ownership, potentially triggering further price declines.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-109853 |
| Document: 0001213900-26-109853-index-headers.html | 0001213900-26-109853 |
| Document: 0001213900-26-109853-index.html | 0001213900-26-109853 |
| Document: 0001213900-26-109853.txt | 0001213900-26-109853 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 10d ago | 8-K | $0.4410 $0.4120 | ▲ +6.58% | ▲ +7.00% | $0.3711 (+15.85%) |
May 21, 2026 22w ago | 8-K | $1.43 $1.42 | ▲ +0.70% | ▲ +1.29% | $0.3711 (+74.05%) |
Apr 7, 2026 28w ago | 8-K | $1.62 $1.52 | ▲ +6.17% | ▲ +6.75% | $0.3711 (+77.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers